Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat by Nazar M. Shareef Mahmood

“…Paraquat (PQ), as a frequently used compound in many applications while the  herbal providing is vigorously used in the curing of broad spectrum diseases such as liver disease, the influence of thyme extract or Thymus vulgaris L. …”
Get full text

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat by Nazar M. Shareef Mahmood

“…Paraquat (PQ), as a frequently used compound in many applications while the  herbal providing is vigorously used in the curing of broad spectrum diseases such as liver disease, the influence of thyme extract or Thymus vulgaris L. …”
Get full text

Demographics, aetiology and outcome of paediatric acute liver failure in Singapore by Fang Kuan Chiou, Veena Logarajah, Christopher Wen Wei Ho, Lynette Suk-Hui Goh, Sivaramakrishnan Venkatesh Karthik, Marion Margaret Aw, Kong Boo Phua

“…PALF was defined by: absence of chronic liver disease; biochemical evidence of acute liver injury; and coagulopathy, non-correctible by vitamin K, defined as prothrombin time (PT) ≥20 seconds or international normalised ratio (INR) ≥2.0 regardless of hepatic encephalopathy (HE) or PT ≥15 seconds or INR ≥1.5 in the presence of HE. …”
Get full text

Treatment compliance of liver cirrhosis patients by Ye. R. Olevskaya, A. I. Dolgushina, A. N. Tarasov, D. S. Mikhaylova, A. R. Molchanova, A. S. Kuznetsova

“…Development of LC was the outcome of viral hepatitis, alcoholic liver disease and other diseases in 13, 14 and 16 patients respectively. …”
Get full text

Targeting ion homeostasis in metabolic diseases: Molecular mechanisms and targeted therapies by Yanjiao Zhang, Kaile Ma, Xinyi Fang, Yuxin Zhang, Runyu Miao, Huifang Guan, Jiaxing Tian

“…The incidence of metabolic diseases—hypertension, diabetes, obesity, metabolic dysfunction-associated steatotic liver disease (MASLD), and atherosclerosis—is increasing annually, imposing a significant burden on both human health and the social economy. …”
Get full text

Rules for investigation of patients with asymptomatic elevation of serum aminotransferase activity by M. V. Mayevskaya, V. T. Ivashkin, Ye. N. German

“…States at which in absence of primary liver disease levels of ALT and AST can raise are described.…”
Get full text

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Inter... by Andrew Trigg, Eric Chan, Helen Kitchen, Tom Willgoss, Kai Fai Ho, Renee Pierson, Jane Scott

“…**Results:** Data from 437 patients were analyzed. Stage of liver disease was associated with symptom severity and functioning at baseline. …”
Get full text

Role of HNF6 in liver homeostasis and pathophysiology by Miaomiao Tian, Weizhen Gao, Shujun Ma, Huiling Cao, Yu Zhang, Fuxiang An, Jianni Qi, Zhen Yang

“…We also highlight gaps in liver disease research and provide future research directions for the application of HNF6 and its downstream molecules as attractive targets in the treatment of liver diseases.…”
Get full text

Liver fibrosis and markers of endothelial function at metabolic syndrome and early disorders of carbohydrate metabolism by L. V. Chesnokova, I. M. Petrov, Ye. A. Sidorova, I. A. Troshina, Yu. A. Petrova

“…Complex estimation of endothelial function at non-alcoholic fatty liver disease (NAFLD) in association with early disorders of carbohydrate metabolism, in relation to liver fibrosis severity.Material and methods. …”
Get full text

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis by Ye. A. Fedos’ina, M. V. Mayevskaya

“…Prevalence of liver steatosis as pathomorphologic substrate of various liver diseases is quite high, however the special attention is given to patients with signs of inflammation and fibrosis, i.e. with confirmed alcohol-induced and non-alcoholic steatohepatitis. …”
Get full text

Prevalence of digestive diseases in patients with excessive body weight and obesity (<i>according to data of polyclinic department of versatile clinic</i>) by I. R. Popova

“…Of diseases of digestive organs the most frequent were: non-alcoholic fatty liver disease (NAFLD) – 83,4 % (r=0,35, p&lt;0,001), non-alcoholic steatohepatitis (NASH) – 13,1% (r=0,14, p&lt;0,001), gallstone disease (GSD) – 41,8 % (r=0,05, p &lt;0,05); steatosis of the pancreas – 86,4% (r=0,20, р&lt;0,001). …”
Get full text

Mesenchymal stem cells-derived exosomes attenuate mouse non-heart-beating liver transplantation through Mir-17-5p-regulated Kupffer cell pyroptosis by Yang Tian, Ming Jin, Nanwei Ye, Zhenzhen Gao, Yuancong Jiang, Sheng Yan

“…Abstract Background Liver transplantation is the most effective treatment for end-stage liver disease. However, the shortage of donor livers has become a significant obstacle to the advancement of liver transplantation. …”
Get full text

Hepatoprotective effects of propolis ethanol extract on D-galactose-induced aging mice: A metabolomics and transcriptomics analysis focusing on insulin resistance pathways by Jinjia Liu, Songhao Tian, Jixiang Wang, Qing Sang, Wenting Su, Jinqiang Wu, Fenglei Zai

“…These findings provide a scientific foundation for the therapeutic potential of PEE in anti-aging and liver disease.…”
Get full text

Liver cirrhosis epidemiology in Chelyabinsk region in 2006-2015 by A. I. Dolgushina, Ye. R. Olevskaya, A. N. Tarasov, M. S. Kazakova, A. Yu. Markina

“…Statistically significant increase of the both total (254.1-391.8 per 100,000 population) and primary (43.3-67.3 per 100,000 population) incidence of the liver diseases was detected. For the 10-year period of monitoring considerable sporadic fluctuations due to the liver diseases were noted. …”
Get full text

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary by Raymond Odhiambo, Jagpreet Chhatwal, Shannon Allen Ferrante, Antoine El Khoury, Elamin Elbasha

“…The lifetime incidence of severe liver disease events (DC, HCC, LT, LD) were projected to decrease by 45% and 61% in treatment-naïve and treatment-experienced patients treated with triple therapy groups in comparison with PEG-RBV treatment. …”
Get full text

Conducting genetic epidemiology research on hyperuricaemia and gout in an indigenous community in Guam - a feasibility study by Yvette C. Paulino, Frank Camacho, Tristan VC Paulino, Delores J. Lee, Lisa Linda Natividad, Elizabeth Matisoo-Smith, Tony R. Merriman, Anna L. Gosling

“…The prevalence of metabolic conditions from highest to lowest were obesity (55.6%), hyperuricaemia (36.0%), hypertension (27.8%), gout (23.0%), diabetes (14.9%), cardiovascular disease (8.4%), kidney disease (7.3%), and liver disease (3.4%). There was variation in the prevalence of metabolic conditions among the major ethnic groups in this study. …”
Get full text

Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies by Jinlin Hou, Thomas Berg, Arndt Vogel, Teerha Piratvisuth, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Katarina Malinowsky, Peter Findeisen, Johannes Kolja Hegel, Wenzel Schöning, Kairat Madin, Konstantin Kroeniger, Henry Lik-Yuen Chan, Ashish Sharma

“…Impact and implications: To improve the detection of early-stage hepatocellular carcinoma (HCC) from benign chronic liver disease (CLD), algorithms combining demographic characteristics and serum biomarkers, such as GAAD and GALAD, have been developed. …”
Get full text

A foundation systematic review of natural language processing applied to gastroenterology & hepatology by Matthew Stammers, Balasubramanian Ramgopal, Abigail Owusu Nimako, Anand Vyas, Reza Nouraei, Cheryl Metcalf, James Batchelor, Jonathan Shepherd, Markus Gwiggner

“…Colonoscopy was the focus of 21 (38.9%) studies; 13 (24.1%) focused on liver disease, 7 (13.0%) on inflammatory bowel disease, 4 (7.4%) on gastroscopy, 4 (7.4%) on pancreatic disease and 2 (3.7%) on endoscopic sedation/ERCP and gastrointestinal bleeding. …”
Get full text

The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials by Mitra Hariri, Masoudreza Sohrabi, Ali Gholami

Get full text

Caroli Disease (Clinical Observation) by I. G. Nikitin, A. A. Karabinenko, A. E. Nikitin, E. I. Dedov, D. G. Zhukova, E. D. Presnova, S. A. Korvyakov, R. H. Azimov, E. V. Reznik

“…The aim of this observation is to describe one case of a rare congenital liver disease – Caroli disease – characterised by a segmented non-obstructive fibrocystic dilation of the intrahepatic bile ducts.Key findings. …”
Get full text